Superstring Capital Management LP
- SEC CIK
- 0001931118
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 35
- 0 vs. Q2 2025
- Portfolio value
- $101.5M
- +$21.2M (+26.5%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ZLABZai Lab Ltd | ADR | 200,628 | $6.80M | 6.7% | +65,733+48.7% | Added | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 68,463 | $6.56M | 6.5% | +68,463 | New | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 789,646 | $5.93M | 5.8% | −497,035−38.6% | Reduced | History |
| ETNB89bio, Inc. | COM | 384,652 | $5.65M | 5.6% | +172,275+81.1% | Added | History |
| IMVTImmunovant, Inc. | COM | 341,348 | $5.50M | 5.4% | +341,348 | New | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 40,893 | $5.39M | 5.3% | −3,214−7.3% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 361,408 | $5.19M | 5.1% | −601,543−62.5% | Reduced | History |
| SVRASavara Inc | COM | 1,309,236 | $4.67M | 4.6% | +193,857+17.4% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 88,658 | $4.60M | 4.5% | −8,108−8.4% | Reduced | History |
| SMMTSummit Therapeutics Inc. | COM | 197,253 | $4.08M | 4.0% | +197,253 | New | History |
| IQVIQVIA Holdings Inc. | Stock | 19,114 | $3.63M | 3.6% | +19,114 | New | History |
| CABACabaletta Bio, Inc. | COM | 1,544,525 | $3.61M | 3.6% | +483,761+45.6% | Added | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 6,401 | $3.60M | 3.5% | +6,401 | New | History |
| DRUGBright Minds Biosciences Inc. | COM NEW | 53,950 | $3.27M | 3.2% | +53,950 | New | History |
| NKTRNektar Therapeutics | COM NEW | 51,270 | $2.92M | 2.9% | +51,270 | New | History |
| INSMINSMED Inc | COM PAR $.01 | 19,786 | $2.85M | 2.8% | +5,215+35.8% | Added | History |
| BCAXBicara Therapeutics Inc. | COM | 175,902 | $2.78M | 2.7% | −13,797−7.3% | Reduced | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 188,080 | $2.39M | 2.4% | +188,080 | New | History |
| SNYSanofi | SPONSORED ADR | 50,407 | $2.38M | 2.3% | +50,407 | New | History |
| ZBIOZenas BioPharma, Inc. | COM | 96,665 | $2.15M | 2.1% | −14,940−13.4% | Reduced | History |
| QUREuniQure N.V. | SHS | 33,175 | $1.94M | 1.9% | +33,175 | New | History |
| TECXTectonic Therapeutic, Inc. | COM | 119,286 | $1.87M | 1.8% | +40,228+50.9% | Added | History |
| URGNUroGen Pharma Ltd. | COM | 87,912 | $1.75M | 1.7% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 360,000 | $1.57M | 1.5% | 00.0% | Unchanged | History |
| KROSKeros Therapeutics, Inc. | COM | 95,083 | $1.50M | 1.5% | +95,083 | New | History |
| SRRKScholar Rock Holding Corp | COM | 39,521 | $1.47M | 1.4% | +39,521 | New | History |
| PTGXProtagonist Therapeutics, Inc | COM | 20,358 | $1.35M | 1.3% | +20,358 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 53,627 | $1.28M | 1.3% | −222,847−80.6% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 89,346 | $1.07M | 1.1% | −255,576−74.1% | Reduced | History |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 34,449 | $888.4K | 0.9% | +8,415+32.3% | Added | History |
| VIRVir Biotechnology, Inc. | COM | 150,312 | $858.3K | 0.8% | +150,312 | New | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 57,644 | $729.2K | 0.7% | +57,644 | New | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 139,886 | $528.8K | 0.5% | +139,886 | New | History |
| BMEABiomea Fusion, Inc. | COM | 250,000 | $505.0K | 0.5% | 00.0% | Unchanged | History |
| IPSCCentury Therapeutics, Inc. | COM | 462,963 | $230.6K | 0.2% | 00.0% | Unchanged | History |
Sold out since Q2 2025 (16)
Positions held at the end of Q2 2025 that are gone from this filing.
| Security | Class | Shares in Q2 2025 | Value in Q2 2025 | % of portfolio in Q2 2025 | History |
|---|---|---|---|---|---|
| VRNAVerona Pharma plc | SPONSORED ADS | 68,982 | $6.52M | 8.1% | History |
| NBIXNeurocrine Biosciences Inc | Stock | 40,608 | $5.10M | 6.4% | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 130,422 | $4.74M | 5.9% | History |
| IONSIonis Pharmaceuticals Inc | COM | 98,267 | $3.88M | 4.8% | History |
| SLNOSoleno Therapeutics Inc | COM | 33,691 | $2.82M | 3.5% | History |
| CYTKCytokinetics Inc | COM NEW | 61,103 | $2.02M | 2.5% | History |
| UTHRUnited Therapeutics Corp | COM | 4,874 | $1.40M | 1.7% | History |
| Avidity Biosciences, Inc.05370A108 | COM | 47,037 | $1.34M | 1.7% | – |
| LQDALiquidia Corp | COM NEW | 71,071 | $885.5K | 1.1% | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 17,623 | $831.8K | 1.0% | History |
| OCULOcular Therapeutix, Inc | COM | 88,980 | $825.7K | 1.0% | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 214,412 | $525.3K | 0.7% | History |
| WVEWave Life Sciences, Inc. | SHS | 70,242 | $456.6K | 0.6% | History |
| KYTXKyverna Therapeutics, Inc. | COM | 142,542 | $437.6K | 0.5% | History |
| SYSo-Young International Inc. | SPONSORED ADS | 72,936 | $226.1K | 0.3% | History |
| Lakeshore Biopharma Co LtdG9845F208 | ORD SHS NEW | 30,792 | $31.4K | <0.1% | – |